Does PAMIDRONATE Cause Second primary malignancy? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Second primary malignancy have been filed in association with PAMIDRONATE (Pamidronate Disodium). This represents 1.5% of all adverse event reports for PAMIDRONATE.
25
Reports of Second primary malignancy with PAMIDRONATE
1.5%
of all PAMIDRONATE reports
2
Deaths
4
Hospitalizations
How Dangerous Is Second primary malignancy From PAMIDRONATE?
Of the 25 reports, 2 (8.0%) resulted in death, 4 (16.0%) required hospitalization.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAMIDRONATE. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does PAMIDRONATE Cause?
Osteonecrosis of jaw (313)
Drug ineffective (180)
Pain (164)
Off label use (143)
Pyrexia (106)
Malignant neoplasm progression (103)
Dyspnoea (102)
Fatigue (97)
Pain in jaw (97)
Metastases to bone (95)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which PAMIDRONATE Alternatives Have Lower Second primary malignancy Risk?
PAMIDRONATE vs PAMIDRONIC ACID
PAMIDRONATE vs PANCRELIPASE
PAMIDRONATE vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE
PAMIDRONATE vs PANCURONIUM
PAMIDRONATE vs PANITUMUMAB